Development and Pharmacokinetics of a Novel Acetylsalicylic Acid Dry Powder for Pulmonary Administration

Development and Pharmacokinetics of a Novel Acetylsalicylic Acid Dry Powder for Pulmonary Administration

Aspirin is an historic blockbuster product, and it has been proposed in a wide range of formulas. Due to exacerbation risks, the pulmonary route has been seldom considered as an alternative to conventional treatments. Only recently, owing to overt advantages, inhalable acetylsalicylic acid dry powde...

Full description

Bibliographic Details
Main Authors: Adam Pacławski, Stavros Politis, Evangelos Balafas, Ekaterini Mina, Paraskevi Papakyriakopoulou, Eirini Christodoulou, Nikolaos Kostomitsopoulos, Dimitrios M. Rekkas, Georgia Valsami, Stefano Giovagnoli
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Pharmaceutics
Subjects:
acetylsalycilic acid
aspirin
dry powders
inhalation
pulmonary delivery
pharmacokinetics
Online Access:https://www.mdpi.com/1999-4923/14/12/2819

Internet

https://www.mdpi.com/1999-4923/14/12/2819

Similar Items